Connection

DAVID NELSON to Transfection

This is a "connection" page, showing publications DAVID NELSON has written about Transfection.
Connection Strength

0.126
  1. Gene replacement therapy for inborn errors of purine metabolism. Cold Spring Harb Symp Quant Biol. 1986; 51 Pt 2:1065-71.
    View in: PubMed
    Score: 0.054
  2. Site-specific phosphorylation of the middle molecular weight human neurofilament protein in transfected non-neuronal cells. J Neurosci. 1990 Jul; 10(7):2428-37.
    View in: PubMed
    Score: 0.019
  3. Ultrastructural analysis of the functional domains in FMRP using primary hippocampal mouse neurons. Neurobiol Dis. 2009 Aug; 35(2):241-50.
    View in: PubMed
    Score: 0.017
  4. Audiogenic seizure susceptibility is reduced in fragile X knockout mice after introduction of FMR1 transgenes. Exp Neurol. 2007 Jan; 203(1):233-40.
    View in: PubMed
    Score: 0.014
  5. Stabilized beta-catenin promotes hepatocyte proliferation and inhibits TNFalpha-induced apoptosis. Lab Invest. 2004 Mar; 84(3):332-41.
    View in: PubMed
    Score: 0.012
  6. The fragile X-related proteins FXR1P and FXR2P contain a functional nucleolar-targeting signal equivalent to the HIV-1 regulatory proteins. Hum Mol Genet. 2000 Jun 12; 9(10):1487-93.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.